Is the AMH Intrafollicular Level a Predictor of the Ploidy Status of the Blastocyst?

ART Fertility Clinics LLC

Status

Enrolling

Conditions

Infertility

Infertility, Female

Treatments

Procedure: OPU - Study Group

Procedure: ICSI

Procedure: Vitrification

Procedure: Culture

Procedure: Denudation - Out of Study

Procedure: Denudation - Study Group

Procedure: Oocyte Pick Up - Out of Study

Genetic: Biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT05837325

2212-ABU-015-LM

Details and patient eligibility

About

To investigate, whether on the day of egg retrieval, after ovarian stimulation for ICSI (intracytoplasmic sperm injection), there is a correlation between the intrafollicular AMH (Anti-Müllerian hormone) levels and the ploidy status of the blastocyst.

Full description

In clinical practice, AMH is used as a diagnostic and/or prognostic marker in women in association with ovulation induction and in various pathophysiological conditions. This study looks to investigate if the hormonal environment that surrounds an oocyte has an impact on the ploidy status of the blastocyst. Nowadays, using NGS (Next Generation Sequencing) platform for analysis of 23 pairs of chromosomes for Preimplantation Genetic Testing on blastocysts, the ploidy status of the embryo is more adequately assessed. Furthermore, embryo culture to blastocyst will provide further information about embryo quality and possibilities of implantation.

To have complete information between the serum hormones, follicular hormones, embryo development and ploidy will provide to clinicians, embryologist and patients further information on embryo selection and adequate ovarian stimulation protocols.

The database will be exported from the clinical information manager, VRepro, to a table in excel format through a database-based query system. The exported data will be duly codified to protect the clinical and personal information of the participants. Prior to the statistical study, an exploratory data analysis will be carried out to review the quality of the information extracted.

Enrollment

300 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

At least one follicle from each ovary at day of trigger
Age from 18 to 40 years old
Normal menstrual cycle of 25-35 days
Poor, normal and high response will be included
First follicle punctured from each ovary will be consider for inclusion: if the COC (Cumulus Oocyte Complex) is present in clear FF (Follicular fluid), the FF will be collected separately for further analysis and the oocyte included in the study

Exclusion criteria